NCT06962787 2025-11-17
A Study of BL-B01D1+TKIĀ±Pembrolizumab in Patients With Locally Advanced or Metastatic Renal Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2 Recruiting
Sichuan Baili Pharmaceutical Co., Ltd.
Jiangsu Alphamab Biopharmaceuticals Co., Ltd